STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2231 by analyst upside · 2026-06-29
MCK
McKesson Corporation
Healthcare · Market Cap $89B · P/E 19.9x
ANALYST PRICE TARGET
+23.3%
implied upside to consensus target
Current Price $763.51
Consensus Target $941.4
Bull Target $1065.0
Bear Target $812.0
Analysts Covering 15
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
9
Hold
4
Sell
0
52-Week Low $637.0
52-Week High $999.0
YTD Return -7.1%
FUNDAMENTALS
Market Cap $89B
P/E Ratio (TTM) 19.9x
Forward P/E 15.2x
EPS (TTM) $38.40
PEG Ratio 1.49
Dividend Yield 0.43%
Revenue (TTM) $403.4B
Profit Margin 1.2%
52-WEEK RANGE
52-Week Low $637.0
52-Week High $999.0
Current Price $763.51
Bear Target $812.0
Bull Target $1065.0
● Now $763.51 ● Target $941.4
TRADING DATA
Avg Volume 1.1M
YTD Return -7.1%
Analyst Count 15
Consensus Buy
Upside to Target +23.3%
Last Updated 2026-06-29

ANALYST SUMMARY

McKesson Corporation (MCK) is currently trading at $763.51 with a Wall Street consensus price target of $941.4, implying potential upside of 23.3% over the next 12 months. 15 analysts currently cover MCK, with a consensus rating of Buy - 75% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $1065.0, while the most cautious has a target of $812.0.

MCK operates in the Healthcare sector with a market capitalisation of $89B. The stock is down 7.1% year-to-date and is currently trading near the lower end of its 52-week range of $637.0 – $999.0.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for MCK, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays — Reiterated
Overweight → Overweight 2026-06-10 Building track record
Citigroup — Reiterated
Buy → Buy 2026-05-14 Building track record
Wells Fargo — Reiterated
Equal-Weight → Equal-Weight 2026-05-12 Building track record
UBS — Reiterated
Buy → Buy 2026-05-08 33% win rate (6 calls)
JP Morgan — Reiterated
Overweight → Overweight 2026-05-08 43% win rate (7 calls)
Evercore ISI Group — Reiterated
Outperform → Outperform 2026-05-08 Building track record
William Blair ● Initiated
Outperform 2026-04-28 44% win rate (9 calls)
UBS — Reiterated
Buy → Buy 2026-04-22 33% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
58
out of 100
Coverage depth
21/30
Consensus clarity
23/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →